Recommandations suisses pour la prise en charge des cancers cutanés chez les patients transplantés d'organe [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]


Autoria(s): Lapointe A.K.; Hofbauer G.; Anliker M.; Arnold A.; Binet I.; Hunger R.; Kempf W.; Pascual M.; Pelloni F.; Serra A.; Laffitte E.
Data(s)

2010

Resumo

Swiss clinical practice guidelines for skin cancer in organ transplant recipients Transplant patients have increased over the last decades. As a consequence of long-term immunosuppression, skin cancer, in particular squamous cell carcinoma (SCC), has become an important problem. Screening and education of potential organ transplant recipients (OTRs) regarding prevention of sun damage and early recognition of skin cancer are important before transplantation. Once transplanted, OTRs should be seen yearly by a dermatologist to ensure compliance with sun avoidance as well as for treatment of precancerosis and SCC. Early removal is the best treatment for SCC. Reduction of immunosuppression, switch to mTOR inhibitors and chemoprevention with acitretin may reduce the incidence of SCC. The dermatological follow-up of OTRs should be integrated into a comprehensive post-transplant management strategy.

Identificador

http://serval.unil.ch/?id=serval:BIB_FD91828E8754

isbn:1660-9379[print], 1660-9379[linking]

pmid:20455382

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 6, no. 246, pp. 854-859

Palavras-Chave #Humans; Immunocompromised Host; Immunosuppressive Agents/adverse effects; Organ Transplantation; Practice Guidelines as Topic; Skin Neoplasms/prevention & control; Switzerland
Tipo

info:eu-repo/semantics/article

article